Journal of Clinical Oncology , 0732-183X
Journal
111 - 120 out of 120Page size: 10
Publications
- Published
Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.
Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.Research output: Contribution to journal › Abstract › peer-review
- Published
Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study
Michael Hawkins, 11 Jun 2007, In: Journal of Clinical Oncology. 25, p. 2833-2839 7 p.Research output: Contribution to journal › Article
- Published
Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data
& 12 others, , 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.Research output: Contribution to journal › Article › peer-review
- Published
Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone
Kaisheng Wen, Sarah Pirrie & Nicholas James, 3 Jun 2013, In: Journal of Clinical Oncology . 31 (supplement), suppl; abstr 5057.Research output: Contribution to journal › Abstract › peer-review
- Published
Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer.
Richard Gray, Kelly Handley, Laura Magill, 7 Nov 2011, In: Journal of Clinical Oncology.Research output: Contribution to journal › Article
- Published
Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
Kelly Handley, Laura Magill, Richard Gray, 1 Apr 2011, In: Journal of Clinical Oncology. 29, 10, p. 1261-1270 10 p.Research output: Contribution to journal › Article
- Published
Virus directed enzyme prodrug therapy: Intratumoural administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer
Daniel Palmer, Vivien Mautner, Stefan Hubscher, Seran Hill, Peter Searle, Lawrence Young, Nicholas James, 29 Mar 2004, In: Journal of Clinical Oncology. 22, p. 1546-1552 7 p.Research output: Contribution to journal › Article
- Published
WARP - A multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs)
Annie Young, Gulnaz Begum, Lucinda Billingham, Daniel Rea, Keith Wheatley, 1 Jan 2005, In: Journal of Clinical Oncology. 23, p. 16SResearch output: Contribution to journal › Abstract
- Published
ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial
David Ferry, Phil Murray, 2002, In: Journal of Clinical Oncology. 20, 9, p. 2240-50 11 p.Research output: Contribution to journal › Article › peer-review
- Published
ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumours: Results of a Phase I trial
Lisette Hammond, David Ferry, Phil Murray, 1 May 2002, In: Journal of Clinical Oncology. 20, 9, p. 2240-2250 11 p.Research output: Contribution to journal › Article